What are the recent discoveries in clinical trials for acute myeloid leukemia?

Gail J. Roboz, USA

During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in acute myeloid leukemia who is based at Weill Cornell Medicine, New York, US. We asked, "Have there been any ground-breaking discoveries recently with clinical trials in acute myeloid leukemia?" In this video, Gail explains that there have been several recent ground-breaking clinical trials, and focuses on those involving targeted agents to IDH1/2 mutations, FLT3 inhibitors, venetoclax, and the recent U.S. Food and Drug Administration (FDA) approval for CC-486 in acute myeloid leukemia maintenance.